Enveda Biosciences logo
Enveda Biosciences · Life sciences

Scientist, Medicinal Chemistry

Enveda Biosciences Hyderabad, IN Posted Nov 11, 2026
Location
Hyderabad, IN
Workplace
On-site / per employer
Posted
Nov 11, 2026

Let’s build the future of medicine—together.

YOUR ROLE

As a Scientist, Medicinal Chemistry at Enveda, you will be at the bench turning ideas into molecules. You will design and run multi-step syntheses, characterize the compounds you make, and work hand in hand with our medicinal chemists to move our programmes forward. Reporting to a Senior Scientist or Principal Scientist, Chemistry, you will be part of a curious, collaborative team in our Hyderabad lab that is helping bring new medicines from nature to patients faster.

WHAT YOU'LL DO

  • ✓Independently design and execute multi-step organic syntheses, from route planning through isolation and purification.
  • ✓Characterize the compounds you make using NMR, LC-MS, HPLC and other analytical techniques, and keep data clean and traceable
  • ✓Work closely with our medicinal chemists and cross-functional teams, and bring creative ideas that add value to our research projects
  • ✓Apply medicinal chemistry principles to support SAR discussions and the design of new analogues
  • ✓Keep our electronic notebooks, internal databases and SOPs up to date, and help protect Enveda's intellectual property

WHAT WE'RE LOOKING FOR

  • ✓PhD degree in Organic or Medicinal Chemistry, with 0-3 years of industry experience
  • ✓Strong practical skills in synthetic organic chemistry techniques and a good knowledge of modern synthetic methods
  • ✓A safety-first mindset and the ability to stay productive and organised in a busy chemistry lab
  • ✓Clear oral and written communication, and a genuine team player who enjoys solving problems together
  • ✓Basic understanding of medicinal chemistry principles; experience with peptide synthesis is a plus

ABOUT ENVEDA

We're a clinical-stage, AI-enabled biotech discovering medicines four times faster than the industry standard.

We recently raised $150M in a Series D, reached unicorn status, and advanced our first drug into Phase 2 trials. Forbes named us one of America's Best Startup Employers. Newsweek recognized us as a Top 100 Most Loved Workplace.

We're building something rare and we're just getting started.

Originally posted by Enveda Biosciences. View original posting